Pages that link to "Q54409492"

The following pages link to Although IL-6 Trans-Signaling Is Sufficient To Drive Local Immune Responses, Classical IL-6 Signaling Is Obligate for the Induction of T Cell-Mediated Autoimmunity (Q54409492):

Displaying 25 items.

• Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling (Q27002391) (← links)
• Mendelian randomization in cardiometabolic disease: challenges in evaluating causality (Q30234302) (← links)
• RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity (Q35780423) (← links)
• Long-term lung transplantation in nonhuman primates (Q36044857) (← links)
• Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex (Q36283919) (← links)
• IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis (Q36577401) (← links)
• The links between chronic obstructive pulmonary disease and comorbid depressive symptoms: role of IL-2 and IFN-γ. (Q37338762) (← links)
• Anti-CD79 antibody induces B cell anergy that protects against autoimmunity. (Q37616437) (← links)
• IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer (Q37850186) (← links)
• Hitting a complex target: an update on interleukin-6 trans-signalling (Q37983123) (← links)
• The problem of choice: current biologic agents and future prospects in RA. (Q38082588) (← links)
• Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure (Q38183314) (← links)
• From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis (Q38336406) (← links)
• IL-6 as a keystone cytokine in health and disease (Q38433045) (← links)
• The Many Faces of Interleukin-6: The Role of IL-6 in Inflammation, Vasculopathy, and Fibrosis in Systemic Sclerosis (Q38525172) (← links)
• Heme oxygenase-1 directly binds STAT3 to control the generation of pathogenic Th17 cells during neutrophilic airway inflammation. (Q38744386) (← links)
• The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis (Q38940024) (← links)
• Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor (Q39459586) (← links)
• Spatiotemporal expression of endogenous TLR4 ligands leads to inflammation and bone erosion in mouse collagen-induced arthritis (Q39503170) (← links)
• Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma. (Q40433122) (← links)
• Temporal and tissue-specific requirements for T-lymphocyte IL-6 signalling in obesity-associated inflammation and insulin resistance (Q42283918) (← links)
• Monoclonal anti-interleukin-6 receptor antibody attenuates donor-specific antibody responses in a mouse model of allosensitization (Q51819771) (← links)
• Deregulated Stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice (Q57651552) (← links)
• Variation in Interleukin 6 Receptor Gene Associates With Risk of Crohn's Disease and Ulcerative Colitis (Q58806184) (← links)
• Effects of interleukin-6 receptor blockade on allergen-induced airway responses in mild asthmatics. (Q64891223) (← links)